PRINCIPAL FINANCIAL GROUP INC

Position in FTRE — Fortrea Holdings Inc.

CIK 1126328 DES MOINES, IA

Position in FTRE

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$4,230,342

-$4,105,254 QoQ

Shares Held

449,081

-7.1% QoQ

Ownership

0.475%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. FTRE ranks #43 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	896,397	$205,032,885
2	VRTX	Vertex Pharmaceuticals Inc / Ma	426,523	$190,459,579
3	INSM	INSMED Inc	916,464	$149,860,192
4	BBIO	BridgeBio Pharma, Inc.	1,330,415	$98,796,617
5	REGN	Regeneron Pharmaceuticals, Inc.	120,425	$93,045,171
6	GPCR	Structure Therapeutics Inc.	1,753,764	$84,531,424
7	CYTK	Cytokinetics Inc	1,093,485	$72,071,595
8	AXSM	Axsome Therapeutics, Inc.	350,488	$59,239,481

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,230,342	449,081	-7.1%	Shares	Defined	2026-05-04
2025-12-31	$8,335,596	483,223	-6.6%	Shares	Defined	2026-02-02
2025-09-30	$4,358,023	517,580	+15.3%	Shares	Defined	2025-11-04
2025-06-30	$2,217,007	448,787	+0.6%	Shares	Defined	2025-08-08
2025-03-31	$3,368,809	446,200	+2.6%	Shares	Defined	2025-04-28
2024-12-31	$8,111,873	434,953	+3.1%	Shares	Defined	2025-01-31
2024-09-30	$8,438,540	421,927	-3.9%	Shares	Defined	2024-10-31
2024-06-30	$10,249,736	439,149	-9.0%	Shares	Defined	2024-07-29
2024-03-31	$19,374,774	482,680	+5.6%	Shares	Defined	2024-04-29
2023-12-31	$15,956,663	457,211	-3.0%	Shares	Defined	2024-02-07
2023-09-30	$13,470,235	471,152	—	Shares	Defined	2023-11-02
No filing history on record for this holder in this stock.